Cargando…

Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer

PURPOSE: To study whether probabilistic selection by the use of a nomogram could improve patient selection for active surveillance (AS) compared to the various sets of rule-based AS inclusion criteria currently used. METHODS: We studied Dutch and Swedish patients participating in the European Random...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venderbos, Lionne D. F., Roobol, Monique J., Bangma, Chris H., van den Bergh, Roderick C. N., Bokhorst, Leonard P., Nieboer, Daan, Godtman, Rebecka, Hugosson, Jonas, van der Kwast, Theodorus, Steyerberg, Ewout W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729867/ https://www.ncbi.nlm.nih.gov/pubmed/26160006 http://dx.doi.org/10.1007/s00345-015-1628-y

Ejemplares similares

Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer
por: Venderbos, Lionne D. F., et al.
Publicado: (2017)

Active surveillance: a review of risk-based, dynamic monitoring
por: Nieboer, Daan, et al.
Publicado: (2018)

Personalized schedules for surveillance of low‐risk prostate cancer patients
por: Tomer, Anirudh, et al.
Publicado: (2018)

Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit
por: Tomer, Anirudh, et al.
Publicado: (2022)

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance
por: Tomer, Anirudh, et al.
Publicado: (2020)

A literature review to understand health literacy in men with prostate cancer on active surveillance
por: Beyer, Katharina, et al.
Publicado: (2023)

Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs
por: Tomer, Anirudh, et al.
Publicado: (2019)

Assessing Discriminative Performance at External Validation of Clinical Prediction Models
por: Nieboer, Daan, et al.
Publicado: (2016)

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
por: Verbeek, Jan F.M., et al.
Publicado: (2019)

Predicting biochemical recurrence and prostate cancer‐specific mortality after radical prostatectomy: comparison of six prediction models in a cohort of patients with screening‐ and clinically detected prostate cancer
por: Remmers, Sebastiaan, et al.
Publicado: (2019)

Improving prediction models with new markers: a comparison of updating strategies
por: Nieboer, D., et al.
Publicado: (2016)

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome
por: Pereira-Azevedo, Nuno, et al.
Publicado: (2018)

Destiny of Insignificance
por: Sillitoe, Alan
Publicado: (1966)

Assessment of heterogeneity in an individual participant data meta‐analysis of prediction models: An overview and illustration
por: Steyerberg, Ewout W., et al.
Publicado: (2019)

Using the Movember Foundation’s GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function—a retrospective study in low-risk prostate cancer patients
por: Crump, R. Trafford, et al.
Publicado: (2021)

Are Clinically Insignificant Prostate Cancers Really Insignificant among Korean Men?
por: Yeom, Chan Dong, et al.
Publicado: (2012)

Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer Rotterdam
por: Hogenhout, Renée, et al.
Publicado: (2022)

Our Cosmic Insignificance
por: Kahane, Guy
Publicado: (2014)

Population‐based, nationwide registration of prostatectomies in Sweden
por: Cazzaniga, Walter, et al.
Publicado: (2019)

The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate
por: Kohestani, Kimia, et al.
Publicado: (2021)

Active surveillance for low-risk prostate cancer: well established, yet avoided?
por: Sosnowski, Roman, et al.
Publicado: (2022)

Abandon the Label of Clinically Insignificant Prostate Cancer
por: Mertens, Laura S., et al.
Publicado: (2022)

Validation of prediction models: examining temporal and geographic stability of baseline risk and estimated covariate effects
por: Austin, Peter C., et al.
Publicado: (2017)

Intraductal carcinoma has a minimal impact on Grade Group assignment in prostate cancer biopsy and radical prostatectomy specimens
por: Rijstenberg, L. Lucia, et al.
Publicado: (2020)

eHealth and mHealth in prostate cancer detection and active surveillance
por: Pereira-Azevedo, Nuno M., et al.
Publicado: (2018)

A seemingly insignificant lesion
por: Sadeghi, Anahita, et al.
Publicado: (2015)

The Moral Insignificance of Self‐consciousness
por: Shepherd, Joshua
Publicado: (2017)

Identifying trauma patients with benefit from direct transportation to Level-1 trauma centers
por: Sewalt, Charlie A., et al.
Publicado: (2021)

Cross-cultural differences in men on active surveillance’ anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance study
por: Dordoni, Paola, et al.
Publicado: (2022)

Performance of IMPACT, CRASH and Nijmegen models in predicting six month outcome of patients with severe or moderate TBI: an external validation study
por: Majdan, Marek, et al.
Publicado: (2014)

The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
por: Remmers, Sebastiaan, et al.
Publicado: (2023)

Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study
por: Godtman, Rebecka Arnsrud, et al.
Publicado: (2021)

Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer
por: Godtman, Rebecka Arnsrud, et al.
Publicado: (2021)

The significance (or the insignificance) of wide pulse pressure
por: Low, Ying Hui, et al.
Publicado: (2016)

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial
por: Wallström, Jonas, et al.
Publicado: (2021)

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer
por: Axén, Elin, et al.
Publicado: (2021)

Suspicious findings on micro-ultrasound imaging and early detection of prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2017)

Platelets, Not an Insignificant Player in Development of Allergic Asthma
por: Luo, Liping, et al.
Publicado: (2021)

Ethnicity and prostate cancer: the way to solve the screening problem?
por: Bokhorst, Leonard P., et al.
Publicado: (2015)

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial
por: Frånlund, Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uvfcg0ffa287aetcnkafvnbk0q